Christina Barbara Walter
Universitätsklinikum Tübingen · 26 works · 31,092 citations · h-index 8
Top works
- PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
- HLA‐G promotes myeloid‐derived suppressor cell accumulation and suppressive activity during human pregnancy through engagement of the receptor ILT4
- Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancer
- The HER2 status of disseminated tumor cells in the bone marrow of early breast cancer patients is independent from primary tumor and predicts higher risk of relapse
- Hematopoietic Stem and Progenitor Cell Expansion in Contact with Mesenchymal Stromal Cells in a Hanging Drop Model Uncovers Disadvantages of 3D Culture
- Possibilities of fertility preservation in young patients with ovarian cancer.
- Clinical characteristics, pathological reevaluation, surgical management and adjuvant therapy of patients with endometrial stromal tumors
- Distribution of the 21-Gene Breast Recurrence Score in Patients with Primary Breast Cancer in Germany
- Attrition in the First Three Therapy Lines in Patients with Advanced Breast Cancer in the German Real-World PRAEGNANT Registry
- Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patients
- Novel workflow analysis of robot-assisted hysterectomy through objective performance indicators: a pilot study
- Sequencing for an interdisciplinary molecular tumor board in patients with advanced breast cancer: experiences from a case series
- Detection and prevalence of disseminated tumor cells from the bone marrow of early stage male breast cancer patients
- A high-risk 70-gene signature is not associated with the detection of tumor cell dissemination to the bone marrow
- Bedarfsgerechte Telemedizin aus Patientinnenperspektive in der klinischen Gynäkologie
- Association between 21-gene-assay and detection of disseminated tumor cells in patients with early breast cancer: results from the IRMA trial
- Selective interaction of triple-negative breast cancer cells with netrin-4 correlates with CD146 expression
- Recurrence Score impacts treatment decisions in hormone receptor-positive, Her2- negative patients with early breast cancer in a real-world setting – results of the IRMA trial
- USP14 als prognostisch relevanter Biomarker und potentieller Kandidat für eine medikamentöse Behandlung der Endometriumkarzinompatientin mit hohem Risiko
- PREVALENCE OF SEROUS TUBAL INTRAEPITHELIAL CARCINOMA (STIC) IN CLINICAL ROUTINE: A RETROSPECTIVE STUDY AT A UNIVERSITY HOSPITAL